Global Pharmaceutical CDMO Services Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 203626
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Pharmaceutical CDMO Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pharmaceutical CDMO Services size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Pharmaceutical CDMO Services market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Pharmaceutical CDMO Services market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Drug Substance Development and Manufacturing

Specialized Services

Lab-based Services

Market segment by Application, can be divided into

Innovative Medicine

Patented Drug

Patent Expired Drug

Market segment by players, this report covers

Recipharm AB

AMRI Global

Patheon N.V.

Aenova Group

Catalent, Inc.

Amatsigroup

WuXi AppTec Group

Strides Pharma Science Limited

Piramal Pharma Solutions

Siegfried Ltd

Fareva Group

FAMAR Health Care Services

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Pharmaceutical CDMO Services

1.2 Classification of Pharmaceutical CDMO Services by Type

1.2.1 Overview: Global Pharmaceutical CDMO Services Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Pharmaceutical CDMO Services Revenue Market Share by Type in 2020

1.2.3 Drug Substance Development and Manufacturing

1.2.4 Specialized Services

1.2.5 Lab-based Services

1.3 Global Pharmaceutical CDMO Services Market by Application

1.3.1 Overview: Global Pharmaceutical CDMO Services Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Innovative Medicine

1.3.3 Patented Drug

1.3.4 Patent Expired Drug

1.4 Global Pharmaceutical CDMO Services Market Size & Forecast

1.5 Global Pharmaceutical CDMO Services Market Size and Forecast by Region

1.5.1 Global Pharmaceutical CDMO Services Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Pharmaceutical CDMO Services Market Size by Region, (2016-2021)

1.5.3 North America Pharmaceutical CDMO Services Market Size and Prospect (2016-2026)

1.5.4 Europe Pharmaceutical CDMO Services Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Pharmaceutical CDMO Services Market Size and Prospect (2016-2026)

1.5.6 South America Pharmaceutical CDMO Services Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Pharmaceutical CDMO Services Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pharmaceutical CDMO Services Market Drivers

1.6.2 Pharmaceutical CDMO Services Market Restraints

1.6.3 Pharmaceutical CDMO Services Trends Analysis

2 Company Profiles

2.1 Recipharm AB

2.1.1 Recipharm AB Details

2.1.2 Recipharm AB Major Business

2.1.3 Recipharm AB Pharmaceutical CDMO Services Product and Solutions

2.1.4 Recipharm AB Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Recipharm AB Recent Developments and Future Plans

2.2 AMRI Global

2.2.1 AMRI Global Details

2.2.2 AMRI Global Major Business

2.2.3 AMRI Global Pharmaceutical CDMO Services Product and Solutions

2.2.4 AMRI Global Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 AMRI Global Recent Developments and Future Plans

2.3 Patheon N.V.

2.3.1 Patheon N.V. Details

2.3.2 Patheon N.V. Major Business

2.3.3 Patheon N.V. Pharmaceutical CDMO Services Product and Solutions

2.3.4 Patheon N.V. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Patheon N.V. Recent Developments and Future Plans

2.4 Aenova Group

2.4.1 Aenova Group Details

2.4.2 Aenova Group Major Business

2.4.3 Aenova Group Pharmaceutical CDMO Services Product and Solutions

2.4.4 Aenova Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Aenova Group Recent Developments and Future Plans

2.5 Catalent, Inc.

2.5.1 Catalent, Inc. Details

2.5.2 Catalent, Inc. Major Business

2.5.3 Catalent, Inc. Pharmaceutical CDMO Services Product and Solutions

2.5.4 Catalent, Inc. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Catalent, Inc. Recent Developments and Future Plans

2.6 Amatsigroup

2.6.1 Amatsigroup Details

2.6.2 Amatsigroup Major Business

2.6.3 Amatsigroup Pharmaceutical CDMO Services Product and Solutions

2.6.4 Amatsigroup Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Amatsigroup Recent Developments and Future Plans

2.7 WuXi AppTec Group

2.7.1 WuXi AppTec Group Details

2.7.2 WuXi AppTec Group Major Business

2.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Product and Solutions

2.7.4 WuXi AppTec Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 WuXi AppTec Group Recent Developments and Future Plans

2.8 Strides Pharma Science Limited

2.8.1 Strides Pharma Science Limited Details

2.8.2 Strides Pharma Science Limited Major Business

2.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Product and Solutions

2.8.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Strides Pharma Science Limited Recent Developments and Future Plans

2.9 Piramal Pharma Solutions

2.9.1 Piramal Pharma Solutions Details

2.9.2 Piramal Pharma Solutions Major Business

2.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Product and Solutions

2.9.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Piramal Pharma Solutions Recent Developments and Future Plans

2.10 Siegfried Ltd

2.10.1 Siegfried Ltd Details

2.10.2 Siegfried Ltd Major Business

2.10.3 Siegfried Ltd Pharmaceutical CDMO Services Product and Solutions

2.10.4 Siegfried Ltd Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Siegfried Ltd Recent Developments and Future Plans

2.11 Fareva Group

2.11.1 Fareva Group Details

2.11.2 Fareva Group Major Business

2.11.3 Fareva Group Pharmaceutical CDMO Services Product and Solutions

2.11.4 Fareva Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Fareva Group Recent Developments and Future Plans

2.12 FAMAR Health Care Services

2.12.1 FAMAR Health Care Services Details

2.12.2 FAMAR Health Care Services Major Business

2.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Product and Solutions

2.12.4 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 FAMAR Health Care Services Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharmaceutical CDMO Services Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Pharmaceutical CDMO Services Players Market Share

3.2.2 Top 10 Pharmaceutical CDMO Services Players Market Share

3.2.3 Market Competition Trend

3.3 Pharmaceutical CDMO Services Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Pharmaceutical CDMO Services Revenue and Market Share by Type (2016-2021)

4.2 Global Pharmaceutical CDMO Services Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Pharmaceutical CDMO Services Revenue Market Share by Application (2016-2021)

5.2 Pharmaceutical CDMO Services Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Pharmaceutical CDMO Services Revenue by Type (2016-2026)

6.2 North America Pharmaceutical CDMO Services Revenue by Application (2016-2026)

6.3 North America Pharmaceutical CDMO Services Market Size by Country

6.3.1 North America Pharmaceutical CDMO Services Revenue by Country (2016-2026)

6.3.2 United States Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

6.3.3 Canada Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

6.3.4 Mexico Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Pharmaceutical CDMO Services Revenue by Type (2016-2026)

7.2 Europe Pharmaceutical CDMO Services Revenue by Application (2016-2026)

7.3 Europe Pharmaceutical CDMO Services Market Size by Country

7.3.1 Europe Pharmaceutical CDMO Services Revenue by Country (2016-2026)

7.3.2 Germany Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

7.3.3 France Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

7.3.5 Russia Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

7.3.6 Italy Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pharmaceutical CDMO Services Revenue by Type (2016-2026)

8.2 Asia-Pacific Pharmaceutical CDMO Services Revenue by Application (2016-2026)

8.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region

8.3.1 Asia-Pacific Pharmaceutical CDMO Services Revenue by Region (2016-2026)

8.3.2 China Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

8.3.3 Japan Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

8.3.4 South Korea Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

8.3.5 India Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

8.3.7 Australia Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Pharmaceutical CDMO Services Revenue by Type (2016-2026)

9.2 South America Pharmaceutical CDMO Services Revenue by Application (2016-2026)

9.3 South America Pharmaceutical CDMO Services Market Size by Country

9.3.1 South America Pharmaceutical CDMO Services Revenue by Country (2016-2026)

9.3.2 Brazil Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

9.3.3 Argentina Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pharmaceutical CDMO Services Revenue by Type (2016-2026)

10.2 Middle East & Africa Pharmaceutical CDMO Services Revenue by Application (2016-2026)

10.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country

10.3.1 Middle East & Africa Pharmaceutical CDMO Services Revenue by Country (2016-2026)

10.3.2 Turkey Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

10.3.4 UAE Pharmaceutical CDMO Services Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pharmaceutical CDMO Services Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Pharmaceutical CDMO Services Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Pharmaceutical CDMO Services Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Pharmaceutical CDMO Services Revenue (USD Million) by Region (2016-2021)

Table 5. Global Pharmaceutical CDMO Services Revenue Market Share by Region (2021-2026)

Table 6. Recipharm AB Corporate Information, Head Office, and Major Competitors

Table 7. Recipharm AB Major Business

Table 8. Recipharm AB Pharmaceutical CDMO Services Product and Solutions

Table 9. Recipharm AB Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. AMRI Global Corporate Information, Head Office, and Major Competitors

Table 11. AMRI Global Major Business

Table 12. AMRI Global Pharmaceutical CDMO Services Product and Solutions

Table 13. AMRI Global Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Patheon N.V. Corporate Information, Head Office, and Major Competitors

Table 15. Patheon N.V. Major Business

Table 16. Patheon N.V. Pharmaceutical CDMO Services Product and Solutions

Table 17. Patheon N.V. Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Aenova Group Corporate Information, Head Office, and Major Competitors

Table 19. Aenova Group Major Business

Table 20. Aenova Group Pharmaceutical CDMO Services Product and Solutions

Table 21. Aenova Group Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Catalent, Inc. Corporate Information, Head Office, and Major Competitors

Table 23. Catalent, Inc. Major Business

Table 24. Catalent, Inc. Pharmaceutical CDMO Services Product and Solutions

Table 25. Catalent, Inc. Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Amatsigroup Corporate Information, Head Office, and Major Competitors

Table 27. Amatsigroup Major Business

Table 28. Amatsigroup Pharmaceutical CDMO Services Product and Solutions

Table 29. Amatsigroup Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. WuXi AppTec Group Corporate Information, Head Office, and Major Competitors

Table 31. WuXi AppTec Group Major Business

Table 32. WuXi AppTec Group Pharmaceutical CDMO Services Product and Solutions

Table 33. WuXi AppTec Group Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Strides Pharma Science Limited Corporate Information, Head Office, and Major Competitors

Table 35. Strides Pharma Science Limited Major Business

Table 36. Strides Pharma Science Limited Pharmaceutical CDMO Services Product and Solutions

Table 37. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Piramal Pharma Solutions Corporate Information, Head Office, and Major Competitors

Table 39. Piramal Pharma Solutions Major Business

Table 40. Piramal Pharma Solutions Pharmaceutical CDMO Services Product and Solutions

Table 41. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Siegfried Ltd Corporate Information, Head Office, and Major Competitors

Table 43. Siegfried Ltd Major Business

Table 44. Siegfried Ltd Pharmaceutical CDMO Services Product and Solutions

Table 45. Siegfried Ltd Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Fareva Group Corporate Information, Head Office, and Major Competitors

Table 47. Fareva Group Major Business

Table 48. Fareva Group Pharmaceutical CDMO Services Product and Solutions

Table 49. Fareva Group Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. FAMAR Health Care Services Corporate Information, Head Office, and Major Competitors

Table 51. FAMAR Health Care Services Major Business

Table 52. FAMAR Health Care Services Pharmaceutical CDMO Services Product and Solutions

Table 53. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Global Pharmaceutical CDMO Services Revenue (USD Million) by Players (2019-2021)

Table 55. Global Pharmaceutical CDMO Services Revenue Share by Players (2019-2021)

Table 56. Breakdown of Pharmaceutical CDMO Services by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Pharmaceutical CDMO Services Players Head Office, Products and Services Provided

Table 58. Pharmaceutical CDMO Services Mergers & Acquisitions in the Past Five Years

Table 59. Pharmaceutical CDMO Services New Entrants and Expansion Plans

Table 60. Global Pharmaceutical CDMO Services Revenue (USD Million) by Type (2016-2021)

Table 61. Global Pharmaceutical CDMO Services Revenue Share by Type (2016-2021)

Table 62. Global Pharmaceutical CDMO Services Revenue Forecast by Type (2021-2026)

Table 63. Global Pharmaceutical CDMO Services Revenue by Application (2016-2021)

Table 64. Global Pharmaceutical CDMO Services Revenue Forecast by Application (2021-2026)

Table 65. North America Pharmaceutical CDMO Services Revenue by Type (2016-2021) & (USD Million)

Table 66. North America Pharmaceutical CDMO Services Revenue by Type (2021-2026) & (USD Million)

Table 67. North America Pharmaceutical CDMO Services Revenue by Application (2016-2021) & (USD Million)

Table 68. North America Pharmaceutical CDMO Services Revenue by Application (2021-2026) & (USD Million)

Table 69. North America Pharmaceutical CDMO Services Revenue by Country (2016-2021) & (USD Million)

Table 70. North America Pharmaceutical CDMO Services Revenue by Country (2021-2026) & (USD Million)

Table 71. Europe Pharmaceutical CDMO Services Revenue by Type (2016-2021) & (USD Million)

Table 72. Europe Pharmaceutical CDMO Services Revenue by Type (2021-2026) & (USD Million)

Table 73. Europe Pharmaceutical CDMO Services Revenue by Application (2016-2021) & (USD Million)

Table 74. Europe Pharmaceutical CDMO Services Revenue by Application (2021-2026) & (USD Million)

Table 75. Europe Pharmaceutical CDMO Services Revenue by Country (2016-2021) & (USD Million)

Table 76. Europe Pharmaceutical CDMO Services Revenue by Country (2021-2026) & (USD Million)

Table 77. Asia-Pacific Pharmaceutical CDMO Services Revenue by Type (2016-2021) & (USD Million)

Table 78. Asia-Pacific Pharmaceutical CDMO Services Revenue by Type (2021-2026) & (USD Million)

Table 79. Asia-Pacific Pharmaceutical CDMO Services Revenue by Application (2016-2021) & (USD Million)

Table 80. Asia-Pacific Pharmaceutical CDMO Services Revenue by Application (2021-2026) & (USD Million)

Table 81. Asia-Pacific Pharmaceutical CDMO Services Revenue by Region (2016-2021) & (USD Million)

Table 82. Asia-Pacific Pharmaceutical CDMO Services Revenue by Region (2021-2026) & (USD Million)

Table 83. South America Pharmaceutical CDMO Services Revenue by Type (2016-2021) & (USD Million)

Table 84. South America Pharmaceutical CDMO Services Revenue by Type (2021-2026) & (USD Million)

Table 85. South America Pharmaceutical CDMO Services Revenue by Application (2016-2021) & (USD Million)

Table 86. South America Pharmaceutical CDMO Services Revenue by Application (2021-2026) & (USD Million)

Table 87. South America Pharmaceutical CDMO Services Revenue by Country (2016-2021) & (USD Million)

Table 88. South America Pharmaceutical CDMO Services Revenue by Country (2021-2026) & (USD Million)

Table 89. Middle East & Africa Pharmaceutical CDMO Services Revenue by Type (2016-2021) & (USD Million)

Table 90. Middle East & Africa Pharmaceutical CDMO Services Revenue by Type (2021-2026) & (USD Million)

Table 91. Middle East & Africa Pharmaceutical CDMO Services Revenue by Application (2016-2021) & (USD Million)

Table 92. Middle East & Africa Pharmaceutical CDMO Services Revenue by Application (2021-2026) & (USD Million)

Table 93. Middle East & Africa Pharmaceutical CDMO Services Revenue by Country (2016-2021) & (USD Million)

Table 94. Middle East & Africa Pharmaceutical CDMO Services Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Pharmaceutical CDMO Services Picture

Figure 2. Global Pharmaceutical CDMO Services Revenue Market Share by Type in 2020

Figure 3. Drug Substance Development and Manufacturing

Figure 4. Specialized Services

Figure 5. Lab-based Services

Figure 6. Pharmaceutical CDMO Services Revenue Market Share by Application in 2020

Figure 7. Innovative Medicine Picture

Figure 8. Patented Drug Picture

Figure 9. Patent Expired Drug Picture

Figure 10. Global Pharmaceutical CDMO Services Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Pharmaceutical CDMO Services Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Pharmaceutical CDMO Services Revenue Market Share by Region (2016-2026)

Figure 13. Global Pharmaceutical CDMO Services Revenue Market Share by Region in 2020

Figure 14. North America Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Pharmaceutical CDMO Services Market Drivers

Figure 20. Pharmaceutical CDMO Services Market Restraints

Figure 21. Pharmaceutical CDMO Services Market Trends

Figure 22. Recipharm AB Recent Developments and Future Plans

Figure 23. AMRI Global Recent Developments and Future Plans

Figure 24. Patheon N.V. Recent Developments and Future Plans

Figure 25. Aenova Group Recent Developments and Future Plans

Figure 26. Catalent, Inc. Recent Developments and Future Plans

Figure 27. Amatsigroup Recent Developments and Future Plans

Figure 28. WuXi AppTec Group Recent Developments and Future Plans

Figure 29. Strides Pharma Science Limited Recent Developments and Future Plans

Figure 30. Piramal Pharma Solutions Recent Developments and Future Plans

Figure 31. Siegfried Ltd Recent Developments and Future Plans

Figure 32. Fareva Group Recent Developments and Future Plans

Figure 33. FAMAR Health Care Services Recent Developments and Future Plans

Figure 34. Global Pharmaceutical CDMO Services Revenue Share by Players in 2020

Figure 35. Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 36. Global Top 3 Players Pharmaceutical CDMO Services Revenue Market Share in 2020

Figure 37. Global Top 10 Players Pharmaceutical CDMO Services Revenue Market Share in 2020

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 39. Global Pharmaceutical CDMO Services Revenue Share by Type in 2020

Figure 40. Global Pharmaceutical CDMO Services Market Share Forecast by Type (2021-2026)

Figure 41. Global Pharmaceutical CDMO Services Revenue Share by Application in 2020

Figure 42. Global Pharmaceutical CDMO Services Market Share Forecast by Application (2021-2026)

Figure 43. North America Pharmaceutical CDMO Services Sales Market Share by Type (2016-2026)

Figure 44. North America Pharmaceutical CDMO Services Sales Market Share by Application (2016-2026)

Figure 45. North America Pharmaceutical CDMO Services Revenue Market Share by Country (2016-2026)

Figure 46. United States Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Canada Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Mexico Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Europe Pharmaceutical CDMO Services Sales Market Share by Type (2016-2026)

Figure 50. Europe Pharmaceutical CDMO Services Sales Market Share by Application (2016-2026)

Figure 51. Europe Pharmaceutical CDMO Services Revenue Market Share by Country (2016-2026)

Figure 52. Germany Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. France Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. United Kingdom Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Russia Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Italy Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Asia-Pacific Pharmaceutical CDMO Services Sales Market Share by Type (2016-2026)

Figure 58. Asia-Pacific Pharmaceutical CDMO Services Sales Market Share by Application (2016-2026)

Figure 59. Asia-Pacific Pharmaceutical CDMO Services Revenue Market Share by Region (2016-2026)

Figure 60. China Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Japan Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South Korea Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. India Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Southeast Asia Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Australia Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South America Pharmaceutical CDMO Services Sales Market Share by Type (2016-2026)

Figure 67. South America Pharmaceutical CDMO Services Sales Market Share by Application (2016-2026)

Figure 68. South America Pharmaceutical CDMO Services Revenue Market Share by Country (2016-2026)

Figure 69. Brazil Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Argentina Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Middle East and Africa Pharmaceutical CDMO Services Sales Market Share by Type (2016-2026)

Figure 72. Middle East and Africa Pharmaceutical CDMO Services Sales Market Share by Application (2016-2026)

Figure 73. Middle East and Africa Pharmaceutical CDMO Services Revenue Market Share by Country (2016-2026)

Figure 74. Turkey Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. UAE Pharmaceutical CDMO Services Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz